314.36
1.14%
3.945
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $314.36, with a volume of 524.63K.
It is up +1.14% in the last 24 hours and up +0.95% over the past month.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$310.41
Open:
$310.4
24h Volume:
524.63K
Relative Volume:
0.96
Market Cap:
$22.56B
Revenue:
$2.88B
Net Income/Loss:
$524.90M
P/E Ratio:
42.42
EPS:
7.41
Net Cash Flow:
$357.10M
1W Performance:
+9.62%
1M Performance:
+0.95%
6M Performance:
-11.42%
1Y Performance:
-2.17%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
Dec-14-22 | Initiated | Deutsche Bank | Hold |
Nov-30-22 | Initiated | UBS | Neutral |
Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
Oct-14-20 | Initiated | Stephens | Equal-Weight |
Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
May-01-19 | Downgrade | Jefferies | Buy → Hold |
Apr-23-19 | Initiated | William Blair | Outperform |
Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
Jan-24-18 | Initiated | Goldman | Neutral |
Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
Oct-03-17 | Initiated | Stephens | Equal-Weight |
Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
Mar-22-16 | Initiated | Wells Fargo | Outperform |
May-14-10 | Reiterated | UBS | Neutral |
Feb-23-10 | Initiated | Jefferies & Co | Buy |
Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
West Pharmaceutical Services Reports Solid Third-Quarter 2024 Results and Raises Guidance - MSN
West to Participate in Upcoming Investor Conferences - Marketscreener.com
On Body Drug Delivery Devices Market: Anticipated Positive - openPR
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Buy These 4 Stocks With New Dividend Hikes Amid Market Volatility - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Hennion & Walsh Asset Management Inc. - MarketBeat
William Blair Brokers Decrease Earnings Estimates for WST - MarketBeat
West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall St
What's in Store for West Pharmaceutical in Q3 Earnings? - MSN
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Announces Earnings Results, Beats Expectations By $0.34 EPS - MarketBeat
West Pharmaceutical Services (NYSE:WST) Stock Price Down 3.6%Should You Sell? - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript - MSN
West Pharmaceutical Adjusts 2024 Guidance Amid Sales Dip - Yahoo Finance
West Pharmaceutical Services, Inc. (NYSE:WST) Plans Dividend Increase$0.21 Per Share - MarketBeat
Earnings call: West Pharmaceutical Services outlines Q3 2024 results - Investing.com
West Pharmaceutical Services Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance - MSN
Raymond James & Associates Grows Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc (WST) Q3 2024 Earnings Call Highlights: Strong Performance ... - Yahoo Finance
West Pharmaceutical Services Inc (WST) Q3 2024 Earnings Call Hig - GuruFocus.com
Tesla, Boeing, UPS, IBM, ServiceNow, Molina, West Pharma, Newmont, and More Movers - Barron's
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend - AOL
West Pharmaceutical Services (NYSE:WST) Shares Gap UpTime to Buy? - MarketBeat
Why Is West Pharmaceutical Stock Soaring On Thursday?West Pharmaceutical Servs (NYSE:WST) - Benzinga
West Pharmaceutical ups FY24 adjusted EPS view to $6.55-$6.75 from $6.35-$6.65 - TipRanks
Monte Financial Group LLC Acquires 1,883 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical gains on annual profit forecast raise - XM
West Pharmaceutical Services Shares Rise 19% after Raising 2024 Outlook - MarketWatch
west pharmaceutical services inc. Positive Earnings Pre-Announcements - RTTNews
West Pharmaceutical raises annual profit forecast on demand for medical supplies - WTVB
West Pharmaceutical: Q3 Earnings Snapshot - CTPost
West Pharmaceutical Services (NYSE:WST) Updates FY 2024 Earnings Guidance - MarketBeat
West Pharmaceutical Ups Forecast On Rising Medical Supply Demand - Finimize
West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance
West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend – Company AnnouncementFT.com - Financial Times
West Pharmaceutical Q3 2024 Earnings Preview - MSN
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceuticals (WST) Fell Due to Industry Headwinds - Yahoo Finance
Fill Finish Manufacturing Market is expected to Double Its Size - openPR
West to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA Conference – Company AnnouncementFT.com - Financial Times
Creative Planning Boosts Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Whittier Trust Co. Buys 1,779 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Net Worth Advisory Group Purchases New Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Swedbank AB Purchases 2,220 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline - Yahoo Finance
West Pharmaceutical Services (WST) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
West Pharmaceutical Services (BSP:W2ST34) Momentum Rank : 9 (As of Oct. 16, 2024) - GuruFocus.com
Simplify your move from a vial to a prefilled syringe - European Pharmaceutical Review
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Ophthalmic Packaging A Game Changer for Global Finance Forecast-Amcor, West Pharmaceutical Service, Gerresheimer, BD, Sc – IndiaPolitics.com - IndiaPolitics.com
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):